Monitoring Agency Report for the quarter ended March 31, 2026
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF submitted its first quarterly monitoring report for IPO fund utilization. The company raised Rs. 90 crore via IPO in February 2026, with net proceeds of Rs. 82.28 crore after Rs. 7.72 crore in issue expenses. Of this, only Rs. 8.69 crore (about 9.7%) has been deployed as of March 31, 2026, leaving Rs. 81.31 crore unutilized. The main utilization was Rs. 7.72 crore for issue expenses and Rs. 0.97 crore for general corporate purposes (BSE/NSE fees and advertisements). No funds were deployed toward the Rs. 50 crore IVF centre expansion or Rs. 20 crore loan repayment during this quarter. The unutilized amount is parked in HDFC Bank fixed deposits earning 7.2-7.27% interest. The monitoring agency notes delays in fund deployment due to commercial and operational considerations but confirms no deviations from the stated objects.
The low deployment rate (only 9.7% utilized in the first quarter post-IPO) indicates the company is taking time before deploying IPO proceeds, possibly due to market conditions or business planning. The funds are safely held in bank FDs earning ~7.2% returns. No immediate shareholder concern as the delays are within permitted limits under the Prospectus.